Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 1/20 | 0.37 |
| ▸ | TERT | O14746 | 4/20 | 0.36 |
| ▸ | GCGR | P47871 | 1/20 | 0.35 |
| ▸ | RAF1 | P04049 | 1/20 | 0.33 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.33 |
| ▸ | TOP1 | P11387 | 1/20 | 0.33 |
| ▸ | CYCS | P99999 | 1/20 | 0.33 |
| ▸ | AURKA | O14965 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17651787 | 1.00 | DHODH (0.37) | DHODHTERTGCGRRAF1ABCG2 | |
| SCHEMBL24221287 | 0.95 | DHODH (0.34) | DHODHTERTGCGRRAF1ABCG2 | |
| SCHEMBL17651794 | 0.91 | TERT (0.38) | DHODHTERTTOP1CYCS | |
| SCHEMBL31679250 | 0.91 | TERT (0.38) | DHODHTERTTOP1CYCS | |
| SCHEMBL31679247 | 0.91 | TERT (0.40) | DHODHTERTTOP1CYCS | |
| SCHEMBL17651785 | 0.91 | TERT (0.40) | DHODHTERTTOP1CYCS | |
| SCHEMBL24221296 | 0.85 | TERT (0.36) | DHODHTERTTOP1CYCS | |
| SCHEMBL24221297 | 0.84 | TERT (0.35) | DHODHTERTRAF1TOP1CYCS | |
| SCHEMBL17651811 | 0.84 | TOP1 (0.43) | DHODHTERTTOP1CYCS | |
| SCHEMBL17651778 | 0.84 | TOP1 (0.43) | DHODHTERTTOP1CYCS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12403127-B2 | Specifically meso-substituted porphyrins and chlorins for photodynamic therapy | BIOLITEC UNTERNEHMENSBETEILIGUNGS II AG (AT) | 2025-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12403127-B2 | Specifically meso-substituted porphyrins and chlorins for photodynamic therapy | DHPS, DDT, PPOX | DHODH 27/4885TERT 1760/4885GCGR 4561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.